Cigna Corp. chart

Last update: 2022-12-29
Key statistics and financials
Revenue per share 553.14
Dividend & YieldN/A£ (N/A)
Beta 0.68
Market capitalization N/A
Operating cash flow 9.67B
ESG Scores 11.6

Company description

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Sector: - Industry:

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 332M 1.34B 1.35B -77M
Total Cashflows From Investing Activities -26.38B -734M 2.98B -3.61B
Net Borrowings 24.21B -5.17B -4.74B 521M
Total Cash From Financing Activities 23.52B -7.19B -8.53B -8.21B
Change To Operating Activities -481M 423M 4.25B 2.6B
Issuance Of Stock 68M 224M 376M 326M
Net Income 2.64B 5.1B 8.46B 5.37B
Change In Cash 883M 813M 4.83B -5.12B
Effect Of Exchange Rate -24M -8M 41M -65M
Total Cash From Operating Activities 3.77B 9.48B 10.35B 7.19B
Depreciation 356M 2.77B 1.8B 1.8B
Change To Account Receivables 705M -713M -1.5B -2.84B
Other Cashflows From Financing Activities -423M -234M -116M 24M
Change To Netincome -11M -472M -4.51B -225M
Capital Expenditures -528M -1.05B -1.09B -1.15B

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 3.58B 6.57B 10.87B 6.78B
Net Income 2.64B 5.1B 8.46B 5.37B
Selling General Administrative 11.14B 13.31B 13.66B 12.81B
Gross Profit 16.25B 25.26B 24.36B 23.16B
Ebit 4.87B 8.99B 8.71B 8.35B
Operating Income 4.87B 8.99B 8.71B 8.35B
Interest Expense -280M -1.6B -1.4B -1.3B
Income Tax Expense 935M 1.45B 2.38B 1.37B
Total Revenue 48.57B 153.74B 160.55B 174.27B
Cost Of Revenue 32.32B 128.49B 136.19B 151.12B
Total Other Income ExpenseNet -1.29B -2.42B 2.15B -1.57B
Net Income From Continuing Ops 2.65B 5.12B 8.49B 5.42B
Net Income Applicable To Common Shares 2.64B 5.1B 8.46B 5.37B

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 112.15B 110.39B 105.06B 107.7B
Total Stockholder Equity 41.03B 45.34B 50.32B 47.11B
Other Current Liabilities 1.43B 8.03B 1.71B 7.77B
Total Assets 153.23B 155.77B 155.45B 154.89B
Common Stock 4M 4M 4M 4M
Other Current Assets 1.24B 10.91B 930M 11.34B
Retained Earnings 15.09B 20.16B 28.57B 32.59B
Treasury Stock -1.81B -3.13B -7.23B -15.06B
Cash 3.85B 4.62B 10.18B 5.08B
Total Current Liabilities 31.89B 40.14B 36.02B 43.57B
Other Stockholder Equity -1.71B -941M -861M -884M
Property, Plant, and Equipment 1.28B 4.95B 1.74B 4.17B
Total Current Assets 20.4B 29.84B 27.79B 36.13B
Net Tangible Assets -45.76B -35.83B -32.52B -32.8B
Net Receivables 10.47B 10.72B 12.19B 15.07B
Accounts Payable 21.52B 20.46B 23.65B 27.28B


Insider Transactions

Here are the insider transactions of stock shares related to Cigna Corp.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
PALMER ERIC P.Sale at price 300.00 per share.D2022-10-14Officer4k
SANFORD PAUL ASale at price 300.00 per share.D2022-10-14Officer373
TRIPLETT MICHAEL WConversion of Exercise of derivative security at price 139.22 per share.D2022-09-13Officer8.51k
TRIPLETT MICHAEL WSale at price 292.76 per share.D2022-09-12Officer8.26k
BRAILER DAVID JStock Award(Grant) at price 0.00 per share.D2022-09-01Officer1.75k
AGOGLIA HOELTZEL MARY TSale at price 286.89 per share.D2022-08-09Officer7.04k
AGOGLIA HOELTZEL MARY TConversion of Exercise of derivative security at price 58.73 per share.D2022-08-09Officer7.04k
SANFORD PAUL ASale at price 285.00 per share.D2022-08-09Officer374
NEVILLE EVERETTSale at price 273.98 per share.D2022-08-01Officer902
SADLER JASON DOMINICConversion of Exercise of derivative security at price 149.13 per share.D2022-07-11Officer12.4k
SADLER JASON DOMINICSale at price 280.00 per share.D2022-07-08Officer9.51k
NEVILLE EVERETTConversion of Exercise of derivative security at price 192.02 per share.D2022-07-08Officer5.56k
PALMER ERIC P.Conversion of Exercise of derivative security at price 120.89 per share.D2022-07-08Officer6.42k
NEVILLE EVERETTSale at price 275.00 per share.D2022-07-07Officer5.09k
PALMER ERIC P.Sale at price 275.00 per share.D2022-07-07Officer6.52k
SANFORD PAUL ASale at price 275.00 per share.D2022-07-07Officer374
SADLER JASON DOMINICConversion of Exercise of derivative security at price 139.22 per share.D2022-06-29Officer4.56k
SADLER JASON DOMINICSale at price 270.00 per share.D2022-06-28Officer3.46k
JONES NICOLE SConversion of Exercise of derivative security at price 139.22 per share.D2022-05-18General Counsel6.78k
CORDANI DAVID MConversion of Exercise of derivative security at price 120.89 per share.D2022-05-18Chief Executive Officer53.13k
JONES NICOLE SSale at price 270.00 per share.D2022-05-17General Counsel5.9k
CORDANI DAVID MSale at price 270.29 - 271.28 per share.D2022-05-17Chief Executive Officer45.26k
DELANEY WILLIAM J IIIStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
MAZZARELLA KATHLEEN M.Stock Award(Grant) at price 0.00 per share.D2022-04-27Director757
ZARCONE DONNA FStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
FOSS ERIC JStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
WISEMAN ERIC CStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
ROSS KIMBERLY AStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
MCCLELLAN MARK BStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
KURIAN GEORGEStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
GRANGER ELDERStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
HATHI NEESHAStock Award(Grant) at price 0.00 per share.D2022-04-27Director757
PARTRIDGE JOHN MStock Award(Grant) at price 0.00 per share.D2022-04-26Director188
PARTRIDGE JOHN M.Stock Award(Grant) at price 0.00 per share.D2022-04-26Director188
JONES NICOLE SConversion of Exercise of derivative security at price 139.22 per share.D2022-04-21General Counsel6.78k
CORDANI DAVID MConversion of Exercise of derivative security at price 120.89 per share.D2022-04-21Chief Executive Officer60.75k
JONES NICOLE SSale at price 265.00 per share.D2022-04-20General Counsel5.92k
CORDANI DAVID MSale at price 265.33 - 269.27 per share.D2022-04-20Chief Executive Officer45.38k
JONES NICOLE SConversion of Exercise of derivative security at price 139.22 per share.D2022-04-19General Counsel6.78k
CORDANI DAVID MSale at price 260.50 - 262.09 per share.D2022-04-19Chief Executive Officer45.51k
CORDANI DAVID MConversion of Exercise of derivative security at price 120.89 per share.D2022-04-19Chief Executive Officer45.51k
JONES NICOLE SSale at price 258.10 - 260.00 per share.D2022-04-18General Counsel12.07k
PALMER ERIC P.Conversion of Exercise of derivative security at price 78.03 per share.D2022-04-07Officer7.97k
SADLER JASON DOMINICSale at price 250.00 per share.D2022-04-06Officer5k
NEVILLE EVERETTSale at price 250.00 per share.D2022-04-06Officer999
PALMER ERIC P.Sale at price 250.00 per share.D2022-04-06Officer8.13k
PALMER ERIC P.Stock Gift at price 0.00 per share.D2022-03-03Officer400
NEVILLE EVERETTSale at price 239.00 per share.D2022-03-02Officer289
DELANEY WILLIAM J IIIStock Award(Grant) at price 0.00 per share.D2022-02-28Director199
JONES NICOLE SSale at price 228.70 per share.D2022-02-28General Counsel2.31k
MAZZARELLA KATHLEEN M.Stock Award(Grant) at price 0.00 per share.D2022-02-28Director199

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Cigna Corp.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Cigna Corp.

Here is the result of two systematic investment strategies applied to Cigna Corp.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Cigna Corp.

The following chart shows the equity curve of the two systematic investment strategies applied to Cigna Corp.:

Cigna Corp. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Cigna Corp.

This is the result of two momentum investment strategies applied to Cigna Corp.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Cigna Corp.

The following chart shows all the entries opened by the momentum investment system on Cigna Corp.:

Cigna Corp. momentum entries
  • The first momentum investment strategy would give 1.37% of return on Cigna Corp.. That represents 2.96£ of latent gain with 215.89£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Cigna Corp.. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

1.37 %

Latent gain

2.96 £

Invested capital

215.89 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Cigna Corp.

The following chart shows the equity curve of the two momentum strategies applied to Cigna Corp.:

Cigna Corp. momentum equity

Note: the dividends potentially given by Cigna Corp. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cigna Corp.

The following chart shows the employed capital evolution of the two momentum strategies on Cigna Corp. since the beginning:

Cigna Corp.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Cigna Corp.

Buy the dip entry openings on Cigna Corp.

Cigna Corp.

The performance achieved by the robo-advisor on Cigna Corp. is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Cigna Corp. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Cigna Corp., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Cigna Corp.

The following chart shows the result of the investment strategy applied to Cigna Corp.:

Cigna Corp.

Note: the dividends potentially given by Cigna Corp. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cigna Corp.

The following chart shows the employed capital evolution since the beginning of the investment strategy on Cigna Corp.:

Cigna Corp.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Cigna Corp.

In this section, I will compare the three previous investment strategies applied to Cigna Corp..

Equity curve comparison on Cigna Corp.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Cigna Corp. investment strategy comparison

Employed capital comparison on Cigna Corp.

Cigna Corp. investment comparison

Performance comparison on Cigna Corp.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0£ 0.0£ 0.0%
Momentum 1 quarter 1.37% 2.96£ 215.89£ 22.83%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Cigna Corp.:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Cigna Corp. and the other stocks. There may be false positives or some missing correlated stocks. If the price of Cigna Corp. does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Cigna Corp.
Country United States
City Bloomfield
Address 900 Cottage Grove Road
Phone 860 226 6000
Website www.cigna.com
FullTime employees 72226
Industry
Sector
Exchange XLON
Ticker 0A77.XLON
Market www.londonstockexchange.com

Cigna Corp. ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0.0
Peer Environment Performance 2.4749180327869
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing no

Social scores

Social ESG Factors Scores
Social Score 6.0
Peer Social Performance 12.44262295082
Social Percentile unknown
Highest Controversy 2
Peer Highest Controversy Performance 1.983606557377
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic no
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Employee IncidentsCustomer IncidentsSociety & Community IncidentsBusiness Ethics Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 5.7
Peer Governance Performance 8.3088524590164
Governance Percentile unknown

ESG at glance
Total ESG Scores: 11.6
Environment Score: 0.0
Social Score: 6.0
Governance Score: 5.7

ESG Performance: UNDER_PERF

Peer Group: Healthcare

Peer Esg Score Performance: 23.226885245902

Rating Year: 2021

Rating Month: 3

Max Age: 86400

Percentile: 3